Heparin-binding EGF-like factor augments esophageal epithelial cell proliferation, migration and inhibits TRAIL-mediated apoptosis via EGFR/MAPK signaling

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 11, 2010, Pages 1350-1359

  Rahman, Farzana Binte ^a   Ishihara, Shunji ^a   Aziz, Md Monowar ^a   Mishima, Yoshiyuki ^a   Oshima, Naoki ^a   Li, Yong Yu ^a   Sanchez Siles, Alvaro A ^a   Otani, Aya ^a   Oka, Akihiko ^a   Kusunoki, Ryusaku ^a   Tada, Yasumasa ^a   Moriyama, Ichiro ^a   Ishimura, Norihisa ^a   Yuki, Takafumi ^b   Kazumori, Hideaki ^a   Amano, Yuji ^b   Sato, Shuichi ^a   Ansary, Mesbah Uddin ^a   Kinoshita, Yoshikazu ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b SHIMANE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Apoptosis; EGF receptor; Esophageal epithelial cell; HB EGF

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME PHOSPHORYLATION; ESOPHAGUS MUCOSA; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

APOPTOSIS; BCL-X PROTEIN; CELL PROLIFERATION; CELLS, CULTURED; EPITHELIAL CELLS; ESOPHAGUS; GENE EXPRESSION REGULATION; GENES, BCL-2; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 77958473358     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2010.499960     Document Type: Article

References (25)

1. Nishi E, Prat A, Hospital V, Elenius K, Klagsbrun M. N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration. EMBO J 2001;20:3342-3350
2. Iwamoto R, Mekada E. ErbB and HB-EGF signaling in heart development and function. Cell Struct Funct 2006;31:1-14.
3. Fitsialos G, Chassot AA, Turchi L, Dayem MA, LeBrigand K, Moreilhon C, et al. Transcriptional signature of epidermal keratinocytes subjected to in vitro scratch wounding reveals selective roles for ERK1/2, p38, and phosphatidylinositol 3-kinase signaling pathways. J Biol Chem 2007;282:15090-15102
4. Xie H, Wang H, Tranguch S, Iwamoto R, Mekada E, Demayo FJ, et al. Maternal heparin-binding-EGF deficiency limits pregnancy success in mice. Proc Natl Acad Sci USA 2007;104:18315-18320
5. Révillion F, Lhotellier V, Hornez L, Bonneterre J, Peyrat JP. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis. Ann Oncol 2008;19:73-80.
6. Lu X, Wang Q, Hu G, Van Poznak C, Fleisher M, Reiss M, et al. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev 2009;23:1882-1894
7. Wang F, Liu R, Lee SW, Sloss CM, Couget J, Cusack JC. Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance. Oncogene 2007;26:2006-2016
8. Raab G, Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1997;1333:F179-99.
9. Katayama M, Kan M. Heparin-binding (fibroblast) growth factors are potential autocrine regulators of esophageal epithelial cell proliferation. In Vitro Cell Dev Biol 1991; 27:533-541
10. Freeman MR, Yoo JJ, Raab G, Soker S, Adam RM, Schneck FX, et al. Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. J Clin Invest 1997;99:1028-1036
11. Hashimoto K, Higashiyama S, Asada H, Hashimura E, Kobayashi T, Sudo K, et al. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J Biol Chem 1994;269: 20060-20066 (Pubitemid 24250928)
12. Zushi S, Shinomura Y, Kiyohara T, Miyazaki Y, Tsutsui S, Sugimachi M, et al. Role of heparin-binding EGF-related peptides in proliferation and apoptosis of activated rasstimulated intestinal epithelial cells. Int J Cancer 1997;73: 917-923
13. Leach RE, Kilburn BA, Petkova A, Romero R, Armant DR. Diminished survival of human cytotrophoblast cells exposed to hypoxia/reoxygenation injury and associated reduction of heparin-binding epidermal growth factor-like growth factor. Am J Obstet Gynecol 2008;198:471.e1-7
14. Chen X, Raab G, Deutsch U, Zhang J, Ezzell RM, Klagsbrun M. Induction of heparin-binding EGF-like growth factor expression during myogenesis. Activation of the gene by MyoD and localization of the transmembrane form of the protein on the myotube surface. J Biol Chem 1995;270:18285-18294
15. Takeuchi K, Motoda Y, Ito F. Role of transcription factor activator protein 1 (AP1) epidermal growth factor-mediated protection against apoptosis induced by a DNA-damaging agent. FEBS J 2006;273:3743-3755
16. Yan F, Cao H, Chaturvedi R, Krishna U, Hobbs SS, Dempsey PJ, et al. Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pyloriinduced apoptosis. Gastroenterology 2009;136:1297-1307
17. Yin J, Yu FS. ERK1/2 mediates wounding- and G-proteincoupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding. Invest Ophthalmol Vis Sci 2009;50:132-139
18. Frenzel A, Grespi F, Chmelewskij W, Villunger A. Bcl2 family proteins in carcinogenesis and the treatment of cancer. Apoptosis 2009;14:584-596
19. Tucker CA, Kapanen AI, Chikh G, Hoffman BG, Kyle AH, Wilson IM, et al. Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levels. Mol Cancer Ther 2008;7:749-758
20. Qiu J, Xiao J, Han C, Li N, Shen X, Jiang H, Cao X. Potentiation of TNF-{alpha}-induced tumor cell apoptosis by a small-molecule inhibitor for anti-apoptotic protein hPEBP4. J Biol Chem 2010;285:12241-12247
21. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995;3:673-682
22. Teraishi F, Kagawa S, Watanabe T, Tango Y, Kawashima T, Umeoka T, et al. ZD1839 (Gefitinib, 'Iressa'), an epidermal growth factor receptor-tyrosine kinase inhibitor, enhances the anti-cancer effects of TRAIL in human esophageal squamous cell carcinoma. FEBS Lett 2005;579:4069-4075
23. Zhang H, Berezov A, Wang Q, Zhang G, Drebin J, Murali R, Greene MI. ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Invest 2007;117:2051-2058
24. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-2139
25. Lurje G, Lenz HJ. EGFR signaling and drug discovery. Oncology 2009;77:400-410